TrialThe oncologist2019

Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer.

Elisabetta Pietri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.